[1] |
LU Renquan, LIU Guangyu, YANG Wentao, GUO Lin, GUAN Ming, SHAO Zhimin, XU Dazhi, NI Ming, TANG Feng, WANG Chaofu, LOU Jiatao, SUN Fenyong, XING Jinliang, PAN Yueyin.
Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy
[J]. China Oncology, 2022, 32(1): 90-96.
|
[2] |
MA Yifei , LIANG Xinjun , WEI Shaozhong .
Prognostic value of inflammatory and immune markers in resectable colorectal cancer
[J]. China Oncology, 2021, 31(9): 845-851.
|
[3] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[4] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[5] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[6] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|
[7] |
DING Gaofeng, GUO Leiming, LU Yufei.
The relationship between expressions of HER2 and BRCA1 and radiotherapy sensitivity in breast cancer patients
[J]. China Oncology, 2021, 31(7): 589-595.
|
[8] |
YANG Jia , LIU Shuyuan , WANG Yingying , LI Yingfu , MA Qianli , LI Yu , WANG Yongrong , LI Chuanyin , TAN Fang .
The association of polymorphisms in TNF-α gene with non-small cell lung cancer in Han population of Yunnan Province
[J]. China Oncology, 2021, 31(7): 616-628.
|
[9] |
GONG Runze, HU Haiyan.
Clinical significance of CCL2 expression in osteosarcoma tissue
[J]. China Oncology, 2021, 31(6): 455-459.
|
[10] |
PENG Zishan, KONG Hui, BAO Zhen, ZHAO Hongxing, LIU Xin, LU Shaohua.
Clinicopathological analysis of 83 cases of multifocal lung adenocarcinoma
[J]. China Oncology, 2021, 31(5): 408-418.
|
[11] |
XIAO Feng , XIAO Jingwen , SHAO Jianguo , CHEN Liyan , GU Chunyan .
The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis
[J]. China Oncology, 2021, 31(5): 419-427.
|
[12] |
WANG Chunjian , NIE Gang , MAO Yan .
The role of TRIP6 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(3): 161-169.
|
[13] |
YI Weili , ZHAO Wencheng , HUANG Dongning , QIN Li , WU Xintian , ZHOU Fei , WU Fengying .
Analysis of immune-related adverse events and its correlation with efficacy of anti-PD-1 monotherapy in advanced non-small cell lung cancer
[J]. China Oncology, 2021, 31(3): 203-211.
|
[14] |
WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming .
Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma
[J]. China Oncology, 2021, 31(3): 212-220.
|
[15] |
YANG Liusong , ZHU Yingfeng , TANG Jianmin .
Ten cases of epithelioid glioblastoma and review of literature
[J]. China Oncology, 2021, 31(2): 114-120.
|